Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 250.55
-11.25 (-4.30%)
At close: Aug 17, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 8.74 billion as of August 17, 2026. Its market cap has increased by 5.87% in one year.
Market Cap
8.74B
Enterprise Value
10.91B
Revenue
6.53B
Ranking
n/a
PE Ratio
15.34
Stock Price
250.55
ChartMarket Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 8.74B, an increase of 394.53%. That is a compound annual growth rate of 7.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 8.74B | 10.30% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amrutanjan Health Care | 14.30B |
| Syncom Formulations (India) | 14.02B |
| Fermenta Biotech | 12.88B |
| Lincoln Pharmaceuticals | 12.28B |
| Bharat Parenterals | 9.30B |
| Kopran | 9.18B |
| Sudarshan Pharma Industries | 8.74B |
| Hexagon Nutrition | 7.86B |